Furthermore, because EYA3’s tyrosine phosphatase activity promotes DNA damage repair, EYA inhibitors could be used as neo-adjuvant therapy to improve the sensitivity of DNA damaging cancer treatments such as radiation and some forms of chemotherapy. Here, EYA3 is linked to cancer.